Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

TENX stock hub

Tenax Therapeutics, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TENXis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

686.5M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

TENX

In the news

Latest news · TENX

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-55.6

P25 -105.6P50 -46.5P75 -3.1

ROIC-37.3

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TENX market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

180

Groups with data

Currency

USD

Showing 180 of 180 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0000034956
Company name	Tenax Therapeutics, Inc.
Country	United States
Country code	US
Cusip	88032L209
Employees	16
Employees Change	10%
Employees Change Percent	166.7
Enterprise value	$589M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US88032L6056
Last refreshed	2026-05-10
Market cap	$686.5M
Market cap category	Small-Cap
Price	$11.66
Price currency	USD
Sector	Healthcare
Sic	2834
Symbol	TENX
Website	https://www.tenaxthera.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-7.66%
FCF yield	-5.21%
P/B ratio	5.1x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-52.6M
Net Income Growth Years	0%
Profit Per Employee	$-3.3M
ROA	-35.08
Roa5y	-115.8
ROCE	-58.09
ROE	-55.64
Roe5y	-273.8
ROIC	-37.28

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-58.7%
Cagr15y	-53.42%
Cagr1y	109.37%
Cagr20y	-44.45%
Cagr3y	-23.45%
Cagr5y	-67.66%
EPS Growth Years	0
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$104.2M
Cash	$97.6M
Current Assets	$104.2M
Current Liabilities	$7.2M
Equity	$97.1M
Liabilities	$7.2M
Long Term Assets	$0
Long Term Liabilities	$0
Net Cash	$97.6M
Net Cash By Market Cap	$14.21
Net Cash Growth	2.86%
Net Debt Equity	$-1.01
Tangible Book Value	$97.1M
Tangible Book Value Per Share	$2.29
WACC	9.74

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	14.56
Net Working Capital	$-494,000
Quick ratio	13.63
Working Capital	$97.1M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-156.8%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-99.99%
1Y total return	109.26%
200-day SMA	10.27
3Y total return	-55.15%
50-day SMA	13.77
50-day SMA vs 200-day SMA	50over200
5Y total return	-99.65%
All Time High	29,942,418.4
All Time High Change	-100%
All Time High Date	1993-04-15
All Time Low	2.77
All Time Low Change	320.94%
All Time Low Date	2024-06-21
ATR	1
Beta	1
Beta1y	-0.1
Beta2y	0.47
Ch YTD	-4.35
High	11.86
High52	18.38
High52 Date	2026-01-14
High52ch	-36.56%
Low	11.41
Low52	5.34
Low52 Date	2025-06-20
Low52ch	118.35%
Ma50ch	-15.34%
Premarket Change Percent	2.92
Premarket Price	$11.99
Premarket Volume	107
Price vs 200-day SMA	13.5%
RSI	36.71
RSI Monthly	31.65
RSI Weekly	48.89
Sharpe ratio	1.34x
Sortino ratio	2.51
Total Return	-156.8%
Tr YTD	-4.35
Tr15y	-100%
Tr1m	-20.08%
Tr1w	-8.76%
Tr3m	-8.41%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	3
Analyst Count Top	2
Analyst Price Target Top	$27
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.4
Operating Income	$-56.4M
Price target	$29.67
Price Target Change	$154
Price Target Change Top	$132

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	25,743,426%
Float Percent	43.72%
Shares Insiders	0.05%
Shares Institutions	18.91%
Shares Out	58,878,278
Shares Qo Q	2.96%
Shares Yo Y	156.8%
Short Float	0.76%
Short Ratio	0.43
Short Shares	0.33

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-55M
Average Volume	639,129.6x
Bv Per Share	2.29
Ch10y	-99.99
Ch15y	-100
Ch1m	-20.08
Ch1w	-8.76
Ch1y	109.3
Ch20y	-100
Ch3m	-8.41
Ch3y	-55.15
Ch5y	-99.65
Ch6m	65.86
Change	0.09%
Change From Open	-1.1
Close	11.65
Days Gap	1.2
Dollar Volume	10,837,433.6
Earnings Date	2026-05-15
Earnings Time	bmo
EBIT	$-56.4M
EPS	$-1.34
F Score	1
FCF	$-35.8M
FCF EV Yield	-6.08x
FCF Per Share	$-0.61
Financing CF	38,514,000
Fiscal Year End	December
Founded	1,967
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-10
Last Report Date	2025-12-31
Last Split Date	2024-01-03
Last Split Type	Reverse
Last10k Filing Date	2026-03-10
Ma150	11.62
Ma150ch	0.39%
Ma20	13.54
Ma20ch	-13.85%
Net CF	2,714,000
Next Earnings Date	2026-05-22
Open	11.79
Optionable	Yes
Position In Range	55.56
Pre Close	11.65
Price Date	2026-05-08
Ptbv Ratio	7.07
Relative Volume	1.45x
Share Based Comp	19,163,000
Tr20y	-100%
Tr6m	65.86%
Us State	North Carolina
Volume	929,454

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does TENX pay a dividend?

Capital-return profile for this ticker.

Performance

TENX stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TENX?

Insider, institutional, and short-interest positioning.

Institutional ownership

+18.9%

Float: +43.7% of shares outstanding

Insider ownership

+0.1%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

TENX momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

36.7

Neutral momentum band

Price vs 200-day MA

+13.5%

50/200-day relationship not available

Beta (5Y)

1.00

Moves roughly with the market

Sharpe ratio

1.34

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TENX

Hub-level FAQ points readers to the deeper analysis pages.

What is the current TENX stock rating?

Tenax Therapeutics, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full TENX analysis?

The full report lives at /stocks/TENX/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for TENX?

The latest report frames TENX around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the TENX page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.